Study of Pembrolizumab Plus Chemotherapy With Lenvatinib for Malignant Pleural Mesothelioma
Conditions
- Malignant Pleural Mesothelioma
Interventions
- DRUG: Lenvatinib
- DRUG: Pemetrexed
- DRUG: Cisplatin/Carboplatin
- DRUG: Pembrolizumab
Sponsor
Hyogo Medical University
Collaborators